2026 -- S 2564 | |
======== | |
LC005074 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2026 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND | |
SUBSTANCE USE DISORDERS | |
| |
Introduced By: Senators Ujifusa, Euer, Mack, Zurier, Murray, Acosta, DiMario, | |
Date Introduced: February 13, 2026 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Sections 27-38.2-1 and 27-38.2-2 of the General Laws in Chapter 27-38.2 |
2 | entitled "Insurance Coverage for Mental Illness and Substance Use Disorders" are hereby amended |
3 | to read as follows: |
4 | 27-38.2-1. Coverage for treatment of mental health and substance use disorders. |
5 | (a) A group health plan and an individual or group health insurance plan shall provide |
6 | coverage for the treatment of mental health and substance use disorders under the same terms and |
7 | conditions as that coverage is provided for other illnesses and diseases. |
8 | (b) Coverage for the treatment of mental health and substance use disorders shall not |
9 | impose any annual or lifetime dollar limitation. |
10 | (c) Financial requirements and quantitative treatment limitations on coverage for the |
11 | treatment of mental health and substance use disorders shall be no more restrictive than the |
12 | predominant financial requirements applied to substantially all coverage for medical conditions in |
13 | each treatment classification. |
14 | (d) Coverage shall not impose non-quantitative treatment limitations for the treatment of |
15 | mental health and substance use disorders unless the processes, strategies, evidentiary standards, |
16 | or other factors used in applying the non-quantitative treatment limitation, as written and in |
17 | operation, are comparable to, and are applied no more stringently than, the processes, strategies, |
18 | evidentiary standards, or other factors used in applying the limitation with respect to |
| |
1 | medical/surgical benefits in the classification. |
2 | (e) The following classifications shall be used to apply the coverage requirements of this |
3 | chapter: (1) Inpatient, in-network; (2) Inpatient, out-of-network; (3) Outpatient, in-network; (4) |
4 | Outpatient, out-of-network; (5) Emergency care; and (6) Prescription drugs. |
5 | (f) Medication-assisted treatment or medication-assisted maintenance services of substance |
6 | use disorders, opioid overdoses, and chronic addiction, including methadone, buprenorphine, |
7 | naltrexone, or other clinically appropriate medications, is included within the appropriate |
8 | classification based on the site of the service. |
9 | (g) Payors shall rely upon provide coverage for substance use disorders, at a minimum, in |
10 | accordance with the criteria of the American Society of Addiction Medicine when developing |
11 | coverage for levels of care for substance use disorder treatment. |
12 | (h) In conducting utilization review relating to service intensity or level of care placement |
13 | for a mental health or substance use disorder, a payor shall exclusively apply the most recent |
14 | version of the age-appropriate patient placement criteria developed by nonprofit professional |
15 | provider associations of the relevant clinical specialty and shall authorize placement at the service |
16 | intensity or level of care consistent with those criteria. If the payor’s application of the relevant |
17 | patient placement criteria is not consistent with the service intensity or level of care placement |
18 | requested by the patient or their provider, any adverse benefit determination notice shall include |
19 | full details of the payor’s assessment under the relevant criteria to the provider and the patient. |
20 | (i) Mental health and substance use disorder coverage and clinical criteria shall not deviate |
21 | from generally accepted standards of care. |
22 | (h)(j) Patients with substance use disorders shall have access to evidence-based, non-opioid |
23 | treatment for pain, therefore coverage shall apply to medically necessary chiropractic care and |
24 | osteopathic manipulative treatment performed by an individual licensed under § 5-37-2. |
25 | (i)(k) Parity of cost-sharing requirements. Regardless of the professional license of the |
26 | provider of care, if that care is consistent with the provider’s scope of practice and the health plan’s |
27 | credentialing and contracting provisions, cost sharing for behavioral health counseling visits and |
28 | medication maintenance visits shall be consistent with the cost sharing applied to primary care |
29 | office visits. |
30 | 27-38.2-2. Definitions. |
31 | For the purposes of this chapter, the following words and terms have the following |
32 | meanings: |
33 | (1) “Financial requirements” means deductibles, copayments, coinsurance, or out-of- |
34 | pocket maximums. |
| LC005074 - Page 2 of 5 |
1 | (2) "Generally accepted standards of care" means standards of care and clinical practice |
2 | that are generally recognized by healthcare providers practicing in relevant clinical specialties such |
3 | as psychiatry, psychology, clinical social work, addiction medicine and counseling, and behavioral |
4 | health treatment, as reflected in sources including, but not limited to, patient placement criteria, |
5 | service intensity determination, and clinical practice guidelines developed by nonprofit |
6 | professional provider associations including, but not limited to, the Level of Care Utilization |
7 | System (LOCUS), the Child and Adolescent Level of Care/Service Intensity Utilization System |
8 | (CALOCUS-CASII), and the Early Childhood Service Intensity Instrument. |
9 | (2)(3) “Group health plan” means an employee welfare benefit plan as defined in 29 U.S.C. |
10 | § 1002(1) to the extent that the plan provides health benefits to employees or their dependents |
11 | directly or through insurance, reimbursement, or otherwise. For purposes of this chapter, a group |
12 | health plan shall not include a plan that provides health benefits directly to employees or their |
13 | dependents, except in the case of a plan provided by the state or an instrumentality of the state. |
14 | (3)(4) “Health insurance plan” means health insurance coverage offered, delivered, issued |
15 | for delivery, or renewed by a health insurer. |
16 | (4)(5) “Health insurers” means all persons, firms, corporations, or other organizations |
17 | offering and assuring health services on a prepaid or primarily expense-incurred basis, including |
18 | but not limited to, policies of accident or sickness insurance, as defined by chapter 18 of this title; |
19 | nonprofit hospital or medical service plans, whether organized under chapter 19 or 20 of this title |
20 | or under any public law or by special act of the general assembly; health maintenance organizations, |
21 | or any other entity that insures or reimburses for diagnostic, therapeutic, or preventive services to |
22 | a determined population on the basis of a periodic premium. Provided, this chapter does not apply |
23 | to insurance coverage providing benefits for: |
24 | (i) Hospital confinement indemnity; |
25 | (ii) Disability income; |
26 | (iii) Accident only; |
27 | (iv) Long-term care; |
28 | (v) Medicare supplement; |
29 | (vi) Limited benefit health; |
30 | (vii) Specific disease indemnity; |
31 | (viii) Sickness or bodily injury or death by accident or both; and |
32 | (ix) Other limited benefit policies. |
33 | (5)(6) “Mental health or substance use disorder” means any mental disorder and substance |
34 | use disorder that is listed in the most recent revised publication or the most updated volume of: |
| LC005074 - Page 3 of 5 |
1 | either the |
2 | (i) The Diagnostic and Statistical Manual of Mental Disorders (DSM) published by the |
3 | American Psychiatric Association or the International Classification of Disease Manual (ICO) |
4 | published by the World Health Organization; provided, that tobacco and caffeine are excluded from |
5 | the definition of “substance” for the purposes of this chapter, or The Diagnostic Classification of |
6 | Mental Health and Developmental Disorders of Infancy and Early Childhood. |
7 | (7) "Nonprofit professional provider association" means a not-for-profit healthcare |
8 | provider professional association or specialty society that is generally recognized by clinicians |
9 | practicing in the relevant clinical specialty and issues peer-reviewed guidelines, criteria, or other |
10 | clinical recommendations developed through a transparent process, including the American |
11 | Psychiatric Association, American Psychological Association, American Society of Addiction |
12 | Medicine, American Academy of Child and Adolescent Psychiatry, and the American Association |
13 | for Community Psychiatry. |
14 | (6)(8) “Non-quantitative treatment limitations” means: (i) Medical management standards; |
15 | (ii) Formulary design and protocols; (iii) Network tier design; (iv) Standards for provider admission |
16 | to participate in a network; (v) Reimbursement rates and methods for determining usual, customary, |
17 | and reasonable charges; and (vi) Other criteria that limit scope or duration of coverage for services |
18 | in the treatment of mental health and substance use disorders, including restrictions based on |
19 | geographic location, facility type, and provider specialty. |
20 | (7)(9) “Quantitative treatment limitations” means numerical limits on coverage for the |
21 | treatment of mental health and substance use disorders based on the frequency of treatment, number |
22 | of visits, days of coverage, days in a waiting period, or other similar limits on the scope or duration |
23 | of treatment. |
24 | SECTION 2. This act shall take effect upon passage. |
======== | |
LC005074 | |
======== | |
| LC005074 - Page 4 of 5 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND | |
SUBSTANCE USE DISORDERS | |
*** | |
1 | This act would provide that for insurance coverage for treatment of mental health and |
2 | substance use disorders, payors would rely upon criteria which reflect generally accepted standards |
3 | of care when developing coverage for levels of care for mental health treatment. This act would |
4 | also provide that payors would not modify clinical criteria to reduce coverage for mental health |
5 | treatment below the level established by the generally accepted standards of care upon which their |
6 | clinical criteria are based. This act would also provide a definition for the term “generally accepted |
7 | standards of care.” |
8 | This act would take effect upon passage. |
======== | |
LC005074 | |
======== | |
| LC005074 - Page 5 of 5 |